1. Home
  2. FHTX vs IMMR Comparison

FHTX vs IMMR Comparison

Compare FHTX & IMMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FHTX
  • IMMR
  • Stock Information
  • Founded
  • FHTX 2015
  • IMMR 1993
  • Country
  • FHTX United States
  • IMMR United States
  • Employees
  • FHTX N/A
  • IMMR N/A
  • Industry
  • FHTX Medicinal Chemicals and Botanical Products
  • IMMR Computer peripheral equipment
  • Sector
  • FHTX Health Care
  • IMMR Technology
  • Exchange
  • FHTX Nasdaq
  • IMMR Nasdaq
  • Market Cap
  • FHTX 278.1M
  • IMMR 251.7M
  • IPO Year
  • FHTX 2020
  • IMMR 1999
  • Fundamental
  • Price
  • FHTX $4.89
  • IMMR $7.00
  • Analyst Decision
  • FHTX Strong Buy
  • IMMR Strong Buy
  • Analyst Count
  • FHTX 8
  • IMMR 2
  • Target Price
  • FHTX $12.63
  • IMMR $12.25
  • AVG Volume (30 Days)
  • FHTX 118.7K
  • IMMR 440.1K
  • Earning Date
  • FHTX 08-05-2025
  • IMMR 08-19-2025
  • Dividend Yield
  • FHTX N/A
  • IMMR 2.62%
  • EPS Growth
  • FHTX N/A
  • IMMR 57.07
  • EPS
  • FHTX N/A
  • IMMR 2.04
  • Revenue
  • FHTX $24,173,000.00
  • IMMR $163,133,000.00
  • Revenue This Year
  • FHTX $33.60
  • IMMR $988.71
  • Revenue Next Year
  • FHTX $5.87
  • IMMR $109.72
  • P/E Ratio
  • FHTX N/A
  • IMMR $3.36
  • Revenue Growth
  • FHTX N/A
  • IMMR 338.21
  • 52 Week Low
  • FHTX $2.95
  • IMMR $6.47
  • 52 Week High
  • FHTX $10.25
  • IMMR $11.38
  • Technical
  • Relative Strength Index (RSI)
  • FHTX 42.08
  • IMMR 38.97
  • Support Level
  • FHTX $4.72
  • IMMR $6.81
  • Resistance Level
  • FHTX $5.24
  • IMMR $7.07
  • Average True Range (ATR)
  • FHTX 0.41
  • IMMR 0.19
  • MACD
  • FHTX -0.16
  • IMMR -0.04
  • Stochastic Oscillator
  • FHTX 13.73
  • IMMR 20.79

About FHTX Foghorn Therapeutics Inc.

Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing it to identify, validate, and potentially drug targets within the system. The company is developing FHD-286, a selective, allosteric ATPase inhibitor, and FHD-609, a protein degrader, to treat hematologic cancers and solid tumors.

About IMMR Immersion Corporation

Immersion Corp is focused on the creation, design, development, and licensing of haptic technologies that allow people to use its sense of touch more fully as it involves engaging with products and experience the digital world. The company's software focuses on applications in mobile devices, wearables, consumer, and gaming devices markets. It generates revenue from royalty and license fees, and development contract and service fees. Geographically, the company generates a majority of its revenue from Japan, followed by Korea, Germany, United States of America and other countries.

Share on Social Networks: